文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

异基因干细胞移植前的清髓性而非非清髓性预处理导致组织损伤,导致真皮巨噬细胞募集而无活性 T 细胞相互作用。

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction.

机构信息

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.

出版信息

Front Immunol. 2018 Feb 27;9:331. doi: 10.3389/fimmu.2018.00331. eCollection 2018.


DOI:10.3389/fimmu.2018.00331
PMID:29535719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5835032/
Abstract

INTRODUCTION: Conditioning regimens preceding allogeneic stem cell transplantation (alloSCT) can cause tissue damage and acceleration of the development of graft-versus-host disease (GVHD). T-cell-depleted alloSCT with postponed donor lymphocyte infusion (DLI) may reduce GVHD, because tissue injury can be restored at the time of DLI. In this study, we investigated the presence of tissue injury and inflammation in skin during the period of hematologic recovery and immune reconstitution after alloSCT. METHODS: Skin biopsies were immunohistochemically stained for HLA class II, CD1a, CD11c, CD40, CD54, CD68, CD86, CD206, CD3, and CD8. HLA class II-expressing cells were characterized as activated T-cells, antigen-presenting cells (APCs), or tissue repairing macrophages. In sex-mismatched patient and donor couples, origin of cells was determined by multiplex analysis combining XY-FISH and fluorescent immunohistochemistry. RESULTS: No inflammatory environment due to pretransplant conditioning was detected at the time of alloSCT, irrespective of the conditioning regimen. An increase in HLA class II-positive macrophages and CD3 T-cells was observed 12-24 weeks after myeloablative alloSCT, but these macrophages did not show signs of interaction with the co-localized T-cells. In contrast, during GVHD, an increase in HLA class II-expressing cells coinciding with T-cell interaction was observed, resulting in an overt inflammatory reaction with the presence of activated APC, activated donor T-cells, and localized upregulation of HLA class II expression on epidermal cells. In the absence of GVHD, patient derived macrophages were gradually replaced by donor-derived macrophages although patient-derived macrophages were detectable even 24 weeks after alloSCT. CONCLUSION: Conditioning regimens cause tissue damage in the skin, but this does not result in a local increase of activated APC. In contrast to the inflamed situation in GVHD, when interaction takes place between activated APC and donor T-cells, the tissue damage caused by myeloablative alloSCT results in dermal recruitment of HLA class II-positive tissue repairing macrophages co-existing with increased numbers of patient- and donor-derived T-cells, but without signs of specific interaction and initiation of an immune response. Thus, the local skin damage caused by the conditioning regimen appears to be insufficient as single factor to provoke GVHD induction.

摘要

简介:异基因造血干细胞移植(alloSCT)前的预处理方案可导致组织损伤和移植物抗宿主病(GVHD)的加速发展。用延迟供者淋巴细胞输注(DLI)的 T 细胞耗竭 alloSCT 可能会降低 GVHD,因为在 DLI 时可以恢复组织损伤。在这项研究中,我们研究了 alloSCT 后造血恢复和免疫重建期间皮肤中的组织损伤和炎症。 方法:对皮肤活检进行 HLA Ⅱ类、CD1a、CD11c、CD40、CD54、CD68、CD86、CD206、CD3 和 CD8 的免疫组化染色。表达 HLA Ⅱ类的细胞被鉴定为活化的 T 细胞、抗原提呈细胞(APCs)或组织修复巨噬细胞。在性染色体不相容的患者和供体夫妇中,通过结合 XY-FISH 和荧光免疫组化的多重分析确定细胞的起源。 结果:无论预处理方案如何,在 alloSCT 时均未检测到由于预处理引起的炎症环境。在清髓性 alloSCT 后 12-24 周,观察到 HLA Ⅱ类阳性巨噬细胞和 CD3 T 细胞的增加,但这些巨噬细胞没有与共定位 T 细胞相互作用的迹象。相反,在 GVHD 期间,观察到与 T 细胞相互作用的 HLA Ⅱ类表达细胞增加,导致存在活化的 APC、活化的供体 T 细胞和表皮细胞 HLA Ⅱ类表达的局部上调的明显炎症反应。在没有 GVHD 的情况下,虽然在 alloSCT 后 24 周仍可检测到患者来源的巨噬细胞,但患者来源的巨噬细胞逐渐被供体来源的巨噬细胞取代。 结论:预处理方案会导致皮肤组织损伤,但不会导致活化的 APC 局部增加。与 GVHD 中的炎症情况不同,当活化的 APC 与供体 T 细胞相互作用时,清髓性 alloSCT 引起的组织损伤会导致 HLA Ⅱ类阳性组织修复巨噬细胞募集到真皮中,同时伴有患者和供体来源的 T 细胞数量增加,但没有特异性相互作用和免疫反应的迹象。因此,预处理方案引起的局部皮肤损伤似乎不足以作为单一因素引发 GVHD 的诱导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/ddd23c8b4429/fimmu-09-00331-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/64608c0f8ecb/fimmu-09-00331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/8c7cdd4be1d3/fimmu-09-00331-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/00319afc81fd/fimmu-09-00331-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/9bb9decd3599/fimmu-09-00331-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/ddd23c8b4429/fimmu-09-00331-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/64608c0f8ecb/fimmu-09-00331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/8c7cdd4be1d3/fimmu-09-00331-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/00319afc81fd/fimmu-09-00331-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/9bb9decd3599/fimmu-09-00331-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0420/5835032/ddd23c8b4429/fimmu-09-00331-g005.jpg

相似文献

[1]
Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction.

Front Immunol. 2018-2-27

[2]
CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.

Front Immunol. 2018-12-18

[3]
Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors.

Exp Hematol. 2003-10

[4]
Competitive Repopulation and Allo-Immunologic Pressure Determine Chimerism Kinetics after T Cell-Depleted Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion.

Transplant Cell Ther. 2023-4

[5]
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

Dan Med Bull. 2007-5

[6]
Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation.

Front Immunol. 2024

[7]
HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion.

Blood. 2013-6-18

[8]
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?

Biol Blood Marrow Transplant. 2015-7

[9]
Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.

Transplantation. 2008-11-27

[10]
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.

J Clin Invest. 2020-9-1

引用本文的文献

[1]
Plasma from patients undergoing allogeneic hematopoietic stem cell transplantation promotes NETOSIS and correlates with inflammatory parameters and clinical severity.

Front Immunol. 2024

[2]
Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation.

Front Immunol. 2024

[3]
Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses.

Front Immunol. 2023

[4]
HTLV-1 infection of donor-derived T cells might promote acute graft-versus-host disease following liver transplantation.

Nat Commun. 2022-11-30

[5]
Risk Factors of Graft-Versus-Host Disease in the Iranian Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience.

Med J Islam Repub Iran. 2021-11-2

本文引用的文献

[1]
Regulatory T cells in skin.

Immunology. 2017-11

[2]
Involvements of γδT Lymphocytes in Acute and Chronic Skin Wound Repair.

Inflammation. 2017-8

[3]
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

Biol Blood Marrow Transplant. 2017-3

[4]
Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives.

Front Immunol. 2016-11-29

[5]
Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion.

Haematologica. 2016-4

[6]
Phenotypic and Functional Properties of Human Steady State CD14+ and CD1a+ Antigen Presenting Cells and Epidermal Langerhans Cells.

PLoS One. 2015-11-25

[7]
Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL.

Bone Marrow Transplant. 2013-8-12

[8]
HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion.

Blood. 2013-6-18

[9]
Macrophage phenotypes during tissue repair.

J Leukoc Biol. 2013-3-15

[10]
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.

Biol Blood Marrow Transplant. 2013-3-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索